269 results
8-K
EX-1.1
OGEN
Oragenics Inc
1 Mar 24
Oragenics Announces Closing of Public Offering
4:05pm
with the rules and regulations of FINRA).
3.18 No Fiduciary Duties. The Company acknowledges and agrees that the Underwriters’ responsibility to the Company … of any responsibility or liability it may otherwise bear in connection with activities in violation of applicable securities laws, rules or regulations
424B5
OGEN
Oragenics Inc
29 Feb 24
Prospectus supplement for primary offering
4:41pm
or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default … by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise
424B5
OGEN
Oragenics Inc
27 Feb 24
Prospectus supplement for primary offering
5:04pm
will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty … or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related
424B5
OGEN
Oragenics Inc
16 Jan 24
Prospectus supplement for primary offering
9:04am
. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case … of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law
8-K
EX-10.1
emki2hso91y1udj 7kvp
29 Dec 23
Completion of Acquisition or Disposition of Assets
7:30am
8-K
wk0g saiils57e9m4
5 Oct 23
Departure of Directors or Certain Officers
5:29pm
8-K
EX-2.1
3fg8ny7
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-10.1
omga3zlgev
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am
8-K
ozaghbcm06xhk w5j4j
10 Apr 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:44pm